Investors

Shareholders

The Company’s issued share capital, as at 11 March 2025, consists of 141,040,915 ordinary shares with a nominal value of US $0.000001 each (“Ordinary Shares”).

Please note that the Company has, through its Articles of Association, elected to be treated as a UK-issuing company. Accordingly, significant shareholdings are disclosed at 3%.

At 11 March 2025 the following interests of shareholders in excess of 3%, have been notified to the Company.

SHAREHOLDERNUMBER OF ORDINARY SHARES HELDORDINARY SHARES AS % OF ISSUED SHARE CAPITAL
Premier Investissement SAS34,549,62324.50%
Kapitalforeningen Wealth Invest22,178,18015.72%
Oxy Capital – SGOIC, S.A.7,532,3455.34%

Directors’ Holdings

SHAREHOLDERNUMBER OF ORDINARY SHARES HELDORDINARY SHARES AS % OF ISSUED SHARE CAPITAL
Ory Weihs3,802,7172.69%
David King47,0200.03%
Marcus Rich41,5930.03%
Julie Markey29,6530.02%

Not In Public Hands

In accordance with the AIM Rule 26 in so far as the Company is aware, at 11 March 2025 the percentage of the Company’s issued share capital that is not in public hands is 28.67%.

SHAREHOLDERNUMBER OF ORDINARY SHARES HELDORDINARY SHARES AS % OF ISSUED SHARE CAPITAL
Premier Investissement SAS34,549,62324.50%
Ory Weihs3,802,7172.69%
Ocorian Trustees (Jersey) Limited **1,973,0761.40%
David King47,0200.03%
Marcus Rich41,5930.03%
Julie Markey29,6530.02%
Total40,443,68228.67%

** Ocorian Trustees (Jersey) Limited is the appointed trustee (the “Trustee “) for the purposes of the Company’s 2017 and 2020 Global Share Incentive Plans (together the “GSIP“). The shares will be used to satisfy future obligations of the Company under the GSIP. Under the terms of the trust agreement, the Trustee has agreed to all entitlements to dividends issued by the Company, in each case, in respect of such shares prior to the transfer of those shares to satisfy the exercise of options pursuant to the terms of the GSIP.